Web Stats Provided By Google Analytics

The Raw Stem Cell News Feed

The Stem Cell Research Newswire: Comprehensive Real-Time News Feed for Stem Cell Research

Tuesday, August 19, 2014

Ruxolitinib for myelofibrosis: Indication of considerable added benefit

In comparison with 'best supportive care', there is an indication that the new drug is better at relieving symptoms, and a hint of longer survival.

http://ift.tt/1sSKfv8

No comments:

Post a Comment

Popular Stem Cell Roundup Posts